Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Randox Launches Confidante®, the Only OTC Product Capable of Testing 10 STIs Simultaneously

Published: Monday, November 12, 2012
Last Updated: Monday, November 12, 2012
Bookmark and Share
Confidante® is a revolutionary new sexual health test. It is the only over-the-counter (OTC) product that can simultaneously detect 10 of the most common sexually transmitted infections (STI) in a single test.

Randox Laboratories, an international diagnostic solutions company headquartered in the UK, has launched Confidante® to offer a reliable and confidential solution for individuals who wish to test at home.

The latest Health Protection Agency (HPA) figures for STIs have shown a significant rise since 2010. For example, Gonorrhoea has increased by 25%, Syphilis by 5% and 1 in 14 people aged 16-24 have Chlamydia. It is clear to see that a reliable, easy to use, confidential test is greatly needed.

Confidante® from Randox offers a simple, accurate and confidential solution. Taking the test is straight-forward, customers just take either a urine or swab sample in the privacy of their own home and then send it to our laboratories for testing. The test comes with its own transport container and postage-paid envelope, ensuring convenience for the customer. Results are supplied directly to the customer via their chosen method (phone, email or post) within a few days. Unlike other products that can only test for 1 or 2 STIs, Confidante® is the first OTC product that allows customers to test for 10 commonly occurring STIs simultaneously in a single test. Confidante® tests for;

1)    Chlamydia trachomatis
2)    Neisseria gonorrhoea
3)    Treponema pallidum (Syphilis)
4)    Herpes Simplex Virus I
5)    Herpes Simplex Virus II
6)    Trichomonas vaginalis
7)    Mycoplasma hominis
8)    Mycoplasma genitalium
9)    Ureaplasma urealyticum
10)    Haemophilus ducreyi (Chancroid)

Confidante® is a cutting-edge testing procedure using molecular diagnostic technology that far exceeds other STI tests currently available. Our highly sensitive testing methods ensure results are extremely accurate. Confidante® allows individuals to take control of their sexual health in a convenient and confidential manner.

STIs spread quickly and easily through unprotected sex, however many STIs do not show any visible symptoms, making it difficult to tell who has one and who does not. Even though STI rates are increasing, many young people are now taking charge of their sexual health. They may decide to take a test for various reasons; if they notice symptoms, change their sexual partner, have unprotected sex or a partner who has tested positive for an STI. STIs which are left undetected or untreated can cause severe long term health problems, including infertility. There has never been a more important time for sexual health testing.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Randox Wins NI Hospital Trusts Business
Randox fought off global competition to win a five year contract to supply quality control products to the Northern Ireland Health & Social Care Trusts.
Monday, December 09, 2013
UK Trade and Investment Joins Hands with Randox
UK Trade and Investment organize healthcare seminars in Pakistan on “Improving Healthcare and Laboratory performance in Pakistan.”
Thursday, May 30, 2013
Newly Launched RIQAS Website Makes EQA Even Simpler for Laboratories Worldwide allows users to easily discover the many benefits offered by the world’s largest External Quality Assessment (EQA) scheme, Randox International Quality Assessment Scheme (RIQAS) and the advantages of implementing EQA in their laboratory.
Monday, March 04, 2013
You Don’t have to be a Scientist to Work in Healthcare
Randox is expanding its workforce with the recent recruitment of 42 individuals throughout October and November.
Thursday, November 15, 2012
Randox Opens New Manufacturing Facility in Bangalore, India
New Bangalore manufacturing facility to enhance product quality, ensure on time delivery and generate excellent customer satisfaction.
Friday, April 27, 2012
Scientific News
Researchers Develop Classification Model for Cancers Caused by KRAS
Most frequently mutated cancer gene help oncologists choose more effective cancer therapies.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Chromosomal Chaos
Penn study forms basis for future precision medicine approaches for Sezary syndrome
Enzyme Malfunction May be Why Binge Drinking Can Lead to Alcoholism
A new study in mice shows that restoring the synthesis of a key brain chemical tied to inhibiting addictive behavior may help prevent alcohol cravings following binge drinking.
Key to Natural Detoxifier’s Reactivity Discovered
Results have implications for health, drug design and chemical synthesis.
New Treatment for Obesity Developed
Researchers at the University of Liverpool, working with a global healthcare company, have helped develop a new treatment for obesity.
New Protein Found in Immune Cells
Immunobiologists from the University of Freiburg discover Kidins220/ARMS in B cells and demonstrate its functions.
Will Brain Palpation Soon Be Possible?
Researchers have developed non-invasive brain imaging technique which provides the same information as physical palpation.
Shaking Up the Foundations of Epigenetics
Researchers at the Centre for Genomic Regulation (CRG) and the University of Barcelona (UB) published a study that challenges some of the current beliefs about epigenetics.
Groundbreaking Computer Program Diagnoses Cancer in Two Days
Researchers have combined genetics with computer science and created a new diagnostic technology can with 85 per cent certainty identify the source of the disease and thus target treatment and, ultimately, improve the prognosis for the patient.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos